Literature DB >> 23997522

Peritonectomy HIPEC-contemporary results, indications.

David L Morris1.   

Abstract

Year:  2013        PMID： 23997522      PMCID： PMC3752351          DOI： 10.3978/j.issn.1000-9604.2013.07.03

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN： 1000-9604            Impact factor:   5.087


× No keyword cloud information.
  11 in total

Review 1.  Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.

Authors:  Kenneth Jaaback; Nick Johnson; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

2.  Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy.

Authors:  Olivier Glehen; François Noel Gilly; Catherine Arvieux; Eddy Cotte; Florent Boutitie; Baudouin Mansvelt; Jean Marc Bereder; Gérard Lorimier; François Quenet; Dominique Elias
Journal:  Ann Surg Oncol       Date:  2010-03-25       Impact factor: 5.344

3.  Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion.

Authors:  Y Yonemura; T Kawamura; E Bandou; S Takahashi; T Sawa; N Matsuki
Journal:  Br J Surg       Date:  2005-03       Impact factor: 6.939

4.  Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy--a journey to becoming a Nationally Funded Peritonectomy Center.

Authors:  Tristan D Yan; Matthew Links; Sal Fransi; Theresa Jacques; Deborah Black; Vanessa Saunders; David L Morris
Journal:  Ann Surg Oncol       Date:  2007-04-27       Impact factor: 5.344

5.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients.

Authors:  N Bakrin; E Cotte; F Golfier; F N Gilly; G Freyer; W Helm; O Glehen; J M Bereder
Journal:  Ann Surg Oncol       Date:  2012-07-24       Impact factor: 5.344

6.  Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Terence C Chua; Brendan J Moran; Paul H Sugarbaker; Edward A Levine; Olivier Glehen; François N Gilly; Dario Baratti; Marcello Deraco; Dominique Elias; Armando Sardi; Winston Liauw; Tristan D Yan; Pedro Barrios; Alberto Gómez Portilla; Ignace H J T de Hingh; Wim P Ceelen; Joerg O Pelz; Pompiliu Piso; Santiago González-Moreno; Kurt Van Der Speeten; David L Morris
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

7.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

Authors:  Tristan D Yan; Marcello Deraco; Dario Baratti; Shigeki Kusamura; Dominique Elias; Olivier Glehen; François N Gilly; Edward A Levine; Perry Shen; Faheez Mohamed; Brendan J Moran; David L Morris; Terence C Chua; Pompiliu Piso; Paul H Sugarbaker
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

8.  Learning curve of combined modality treatment in peritoneal surface disease.

Authors:  R M Smeenk; V J Verwaal; F A N Zoetmulder
Journal:  Br J Surg       Date:  2007-11       Impact factor: 6.939

9.  Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy.

Authors:  Daniel L Chan; David L Morris; Archana Rao; Terence C Chua
Journal:  Cancer Manag Res       Date:  2012-11-23       Impact factor: 3.989

10.  Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC.

Authors:  Paolo Sammartino; Simone Sibio; Daniele Biacchi; Maurizio Cardi; Fabio Accarpio; Pietro Mingazzini; Maria Sofia Rosati; Tommaso Cornali; Angelo Di Giorgio
Journal:  Gastroenterol Res Pract       Date:  2012-05-08       Impact factor: 2.260
View more
  5 in total

Review 1.  Pseudomyxoma Peritonei: Case Report and Literature Review.

Authors:  Keishla M García; Karla M Flores; Alejandro Ruiz; Frances L González; Ángel M Rodríguez
Journal:  J Gastrointest Cancer       Date:  2019-12

Review 2.  Comprehensive Understanding and Evolutional Therapeutic Schemes for Pseudomyxoma Peritonei: A Literature Review.

Authors:  Suiting Ye; Song Zheng
Journal:  Am J Clin Oncol       Date:  2022-04-14       Impact factor: 2.787

3.  Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis.

Authors:  Maciej Nowacki; Marek Wisniewski; Karolina Werengowska-Ciecwierz; Katarzyna Roszek; Joanna Czarnecka; I Łakomska; Tomasz Kloskowski; Dominik Tyloch; Robert Debski; Katarzyna Pietkun; Marta Pokrywczynska; Dariusz Grzanka; Rafał Czajkowski; Gerard Drewa; A Jundziłł; Joseph K Agyin; Samy L Habib; Artur P Terzyk; Tomasz Drewa
Journal:  Oncotarget       Date:  2015-09-08

4.  A case report of Hepatoid Carcinoma of the Ovary with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy without systemic adjuvant therapy.

Authors:  Samer A Naffouje; Richard R Anderson; George I Salti
Journal:  Int J Surg Case Rep       Date:  2016-08-17

5.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal carcinomatosis from a pancreatic cystadenocarcinoma: A case report.

Authors:  Sophia D Lin; Mikael L Soucisse; Joshua Lansom; David L Morris
Journal:  Int J Surg Case Rep       Date:  2019-09-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.